KIENDRA Trademark

Trademark Overview


On Wednesday, October 16, 2013, a trademark application was filed for KIENDRA with the United States Patent and Trademark Office. The USPTO has given the KIENDRA trademark a serial number of 86092702. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 12, 2017. This trademark is owned by Novartis AG. The KIENDRA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations ...
kiendra

General Information


Serial Number86092702
Word MarkKIENDRA
Filing DateWednesday, October 16, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 12, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2014

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 23, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, June 12, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 12, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2016EXTENSION 5 GRANTED
Thursday, November 3, 2016EXTENSION 5 FILED
Thursday, November 3, 2016TEAS EXTENSION RECEIVED
Friday, May 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 5, 2016EXTENSION 4 GRANTED
Monday, May 2, 2016EXTENSION 4 FILED
Monday, May 2, 2016TEAS EXTENSION RECEIVED
Thursday, October 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2015EXTENSION 3 GRANTED
Friday, October 23, 2015EXTENSION 3 FILED
Friday, October 23, 2015TEAS EXTENSION RECEIVED
Saturday, June 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 5, 2015EXTENSION 2 GRANTED
Monday, May 4, 2015EXTENSION 2 FILED
Thursday, June 4, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 4, 2015TEAS EXTENSION RECEIVED
Thursday, November 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 4, 2014EXTENSION 1 GRANTED
Tuesday, November 4, 2014EXTENSION 1 FILED
Tuesday, November 4, 2014TEAS EXTENSION RECEIVED
Tuesday, May 6, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 31, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 31, 2014ASSIGNED TO EXAMINER
Wednesday, October 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 19, 2013NEW APPLICATION ENTERED IN TRAM